drugset / Trial / NCT04580355

Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome

NCT04580355 ↗

Phase 4 Unknown 30 enrolled University of Campinas, Brazil
RandomizedParallel-groupTriple-blindTreatment

Summary

Periodontitis is an inflammatory disease characterized by a dysbiotic microbiome which can lead to bone destruction and tooth loss. Several studies had been reported the association to periodontal disease with systemic conditions and this relation suggests and axis that links oral and gut microbiome. In order to clarify the impact of periodontal condition on gut microbiome, we aim to evaluate the clinical, immunological parameters and the microbiological condition by sequencing of subgingival biofilm and stool samples both before and after non-surgical periodontal treatment with and without antibiotics as adjunct.

Timeline

Start
2021-07
Primary completion
2022-07
Completion
2022-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 500 mg —
Comparator Metronidazole Small molecule 400 mg —

Indications